Cemplicity, a global digital healthcare company focused on improving patient-reported experiences (PREMs) & patient-reported outcomes (PROMs)
Statistical analysis was performed using IBM SPSS Statistics software, version 20.0. Results: After exclusion of non-eligible respondents, the final sample for the analysis was 261 cases (51% male), resulting in 52.2%of response rate. The mean age of ...
The Journal of Patient-Reported Outcomes (JPRO) is an international, open access, multi-disciplinary journal publishing original manuscripts in the field of patient-reported outcomes (PROs). Listed below are some examples of the types of papers to be considered for publication in JPRO. 1) PROs ...
The level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic review. Support Care Cancer. 2015;23(12):3645-3652. doi:10.1007/s00520-015-2923-2PubMedGoogle ScholarCrossref 2. Laugsand EA, Sprangers MAG, ...
Table 1. Demographics of subjects who completed the patient-reported outcomes (PROMS) questionnaire after maxillomandibular advancement (MMA) surgery. Data are number unless otherwise stated. Empty CellNo. (n = 10) Total number included for analysis 10 Mean (range) age (years) 49.9 (36–65) ...
CODE collects patient reported outcomes quietly while you work. Improve quality of care, meet your data reporting goals, and more.
Centre for Patient Reported Outcome Research. International consensus guidance on the inclusion of patient-reported outcomes (PROs) in clinical trial protocols: the SPIRIT-PRO Extension. 2017.https://www.birmingham.ac.uk/research/activity/mds/centres/cpror/research/spirit-pro.aspx. Accessed August 21...
Patient-reported outcomes were collected by telephone or electronically. Failure of meniscus surgery was defined as subsequent TKA or a VAS score > 27/100, based on prior literature which established this threshold as the patient acceptable symptom state (PASS) for knee pain [18]. The primary ou...
Limited data describe patient-reported outcomes (PROs) of localised oesophageal cancer treated with definitive chemoradiotherapy(CRT). The phase 2/3 SCOPE-1 trial assessed the effectiveness of CRT±cetuximab. The trial for the first time provided an opportunity to describe PROs from a multi-centre ...
Food and Drug Administration; FIS, fatigue impact scale; HRQoL, health-related quality of life; LDQoL, liver disease quality of life questionnaire; LDSI, liver disease symptom index; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; PROs, patient-reported outcomes. ...